Effects of 8-week chokeberry extract supplementation on nitric oxide metabolites, immune markers, and oxidative stress in elite rowers: a randomized controlled trial
Sabina Kaczmarczyk, Joanna Ostapiuk–Karolczuk, Justyna Cichoń-Woźniak, Hanna Dziewiecka, Piotr Basta, Anna Skarpańska-Stejnborn · Scientific Reports · 2026
This randomized controlled trial investigated the effects of 8-week chokeberry extract supplementation on nitric oxide (NO) metabolites, oxidative stress markers, inflammatory cytokines, and white blood cell (WBC) profiles in elite male rowers. Fifteen athletes received either chokeberry extract ( n = 7; 3 × 200 mg/day) or placebo ( n = 8). A 2000-m rowing test was performed before and after supplementation, with blood collected pre-exercise, post-exercise, and 24 h post-exercise. After supplementation, the chokeberry group showed higher plasma nitrite concentrations post-exercise ( p = 0.0183, d = 1.95) and during recovery ( p = 0.0034, d = 2.99), higher post-exercise nitrate levels ( p = 0.0242, d = 1.45) as well as a higher total NOx (NO₂⁻ + NO₃⁻) post-exercise ( p = 0.0114, d = 1.57) compared with placebo. Group differences were also observed in WBC subsets during the post-supplementation test, including lower lymphocytes post-exercise ( p = 0.0075, d = 1.19), higher monocytes pre-exercise ( p = 0.0128, d = 1.03) and post-exercise ( p = 0.0086, d = 1.45), and higher granulocytes post-exercise ( p = 0.0077, d = 1.40) in the supplemented group. No between-group effects were detected for TAOC, TBARS, IL-2, IL-10, or TNF-α. Additionally, after supplementation before exercise, IL-6 levels were higher in the supplemented group compared to the placebo group ( p = 0.0407, d = 1.05). These
Findings: indicate that chokeberry extract supplementation modifies NO-related biomarkers and selected immune parameters during exercise and recovery in elite rowers. The
Results: demonstrate that chokeberry extract can influence physiological responses to intensive training in this athletic population. Trial registration : The study was registered on clinicaltrials.gov ID NCT06133751.